Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06592170
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-07
Brief Title:
Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients MZL
Sponsor:
Organization:
None